Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akhil Varshney

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2021
Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degenerationMeenakshi Ambati, Ivana Apicella, Shao-Bin Wang, et al.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Science Immunology|December 3, 2021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAsShao-Bin Wang, Siddharth Narendran, Shuichiro Hirahara, et al.
Nature Communications|September 24, 2020
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes developmentJayakrishna Ambati, Joseph Magagnoli, Hannah Leung, et al.
Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.
Science Advances|September 29, 2021
<i>Alu</i> complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunityShinichi Fukuda, Siddharth Narendran, Akhil Varshney, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Cytoplasmic synthesis of endogenous <i>Alu</i> complementary DNA via reverse transcription and implications in age-related macular degenerationShinichi Fukuda, Akhil Varshney, Benjamin J Fowler, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2021
Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degenerationMeenakshi Ambati, Ivana Apicella, Shao-Bin Wang, et al.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Science Immunology|December 3, 2021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAsShao-Bin Wang, Siddharth Narendran, Shuichiro Hirahara, et al.
Nature Communications|September 24, 2020
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes developmentJayakrishna Ambati, Joseph Magagnoli, Hannah Leung, et al.
Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.
Science Advances|September 29, 2021
<i>Alu</i> complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunityShinichi Fukuda, Siddharth Narendran, Akhil Varshney, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Cytoplasmic synthesis of endogenous <i>Alu</i> complementary DNA via reverse transcription and implications in age-related macular degenerationShinichi Fukuda, Akhil Varshney, Benjamin J Fowler, et al.
Pageof 3